{"id":"W2127833912","doi":"10.2337/dc09-0517","title":"A Study of Dapagliflozin in Patients With Type 2 Diabetes Receiving High Doses of Insulin Plus Insulin Sensitizers","year":2009,"lang":"en","type":"article","venue":"Diabetes Care","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":362,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"AstraZeneca; Bristol-Myers Squibb; American Diabetes Association","keywords":"Medicine; Dapagliflozin; Insulin; Diabetes mellitus; Type 2 diabetes; Internal medicine; Type 1 diabetes; Endocrinology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007679730796582718,"score_gpt":0.2210316849836143,"score_spread":0.2133519541870316,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}